Page last updated: 2024-11-04

temozolomide and Complex and Mixed Neoplasms

temozolomide has been researched along with Complex and Mixed Neoplasms in 2 studies

Research Excerpts

ExcerptRelevanceReference
" In addition, microsatellite instability, leading to the putative mechanism of temozolomide (TMZ) resistance, was frequently detected."3.79Pediatric glioblastoma with oligodendroglioma component: aggressive clinical phenotype with distinct molecular characteristics. ( Amano, T; Fujioka, Y; Hata, N; Iwaki, T; Mizoguchi, M; Murata, H; Nakamizo, A; Sasaki, T; Suzuki, SO; Yoshimoto, K, 2013)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mizoguchi, M1
Hata, N1
Suzuki, SO1
Fujioka, Y1
Murata, H1
Amano, T1
Nakamizo, A1
Yoshimoto, K1
Iwaki, T1
Sasaki, T1
Goda, JS1
Lewis, S1
Agarwal, A1
Epari, S1
Churi, S1
Padmavati, A1
Gupta, T1
Shetty, P1
Moiyadi, A1
Jalali, R1

Other Studies

2 other studies available for temozolomide and Complex and Mixed Neoplasms

ArticleYear
Pediatric glioblastoma with oligodendroglioma component: aggressive clinical phenotype with distinct molecular characteristics.
    Neuropathology : official journal of the Japanese Society of Neuropathology, 2013, Volume: 33, Issue:6

    Topics: Brain Neoplasms; Chemoradiotherapy; Child; Dacarbazine; Fatal Outcome; Glioblastoma; Humans; Male; M

2013
Impact of oligodendroglial component in glioblastoma (GBM-O): Is the outcome favourable than glioblastoma?
    Clinical neurology and neurosurgery, 2015, Volume: 135

    Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Brain Ne

2015